![MA-based-Elemind-Secures-12Million-in-Seed-Funding MA-based Elemind secures $12million in seed funding. Supporters included the creators of Skype, Nest, Opentable, Broadvision, Boston Scientific, Vital Proteins, Fab Fit Fun, Village Global, LDV Partners, E14 Fund, and Wharton's Alumni Angel fund.](https://startuprise.io/wp-content/uploads/2024/02/MA-based-Elemind-Secures-12Million-in-Seed-Funding.webp)
![MA-based Elemind secures $12million in seed funding. Supporters included the creators of Skype, Nest, Opentable, Broadvision, Boston Scientific, Vital Proteins, Fab Fit Fun, Village Global, LDV Partners, E14 Fund, and Wharton's Alumni Angel fund.](https://startuprise.io/wp-content/uploads/2024/02/MA-based-Elemind-Secures-12Million-in-Seed-Funding.webp)
MA-based Elemind secures $12million in seed funding. Supporters included the creators of Skype, Nest, Opentable, Broadvision, Boston Scientific, Vital Proteins, Fab Fit Fun, Village Global, LDV Partners, E14 Fund, and Wharton’s Alumni Angel fund.
Read also – IL-based Kin Secures $15Million in Funding
The cash will be used by the company to advance the development of its initial product in preparation for its introduction in the upcoming months. Elemind, a neurotech health firm led by CEO Meredith Perry, is at the forefront of “electric medicine,” a non-invasive wearable neurotech approach that uses a novel algorithm that scans and reacts to individual brainwaves to monitor and treat problems in real-time.
Read also – Ca-based Ambience Healthcare Secures $70Million in Series B Round Funding
The company’s wearable neurotechnology reads each person’s brainwaves and responds with customized stimulation to guide them in real-time.
About Elemind
Elemind is a neurotechnology firm that creates products that modify brain states and sculpt brainwaves using cutting-edge neuromodulation techniques. To unleash the potential of neurotechnology, Elemind, the brightest scientists, engineers, and thinking leaders on the planet, are collaborating. Elemind’s technology is backed by multiple papers in peer-reviewed scientific journals and five clinical trials.
Read also – SC-based 6AM City Secures an Undisclosed Amount in Series A Round Funding